EXC.NASDAQExelon CORP

Form 4: Exelon Director's Future Equity Transactions Revealed

Sentiment:

Insider Transaction Report


An SEC Form 4 filing details future equity transactions by Exelon Corp. Director William P Bowers, including acquisitions of deferred stock units and phantom shares, and a disposal of common stock, all scheduled for September 30, 2025.

Summary

  • Director William P Bowers reported future equity transactions for Exelon Corp. (EXC) scheduled for September 30, 2025.
  • The transactions are made pursuant to a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
  • Acquisition of 950 common stock-deferred stock units at a price of $43.43 per unit, increasing indirect beneficial ownership to 17,838 units.
  • The indirect beneficial ownership of deferred stock units includes 154 additional shares acquired through automatic dividend reinvestment.
  • Disposal of 4,500 shares of common stock.
  • Acquisition of 1,805 deferred phantom share equivalents at a price of $45.01 per equivalent, increasing direct beneficial ownership to 17,097 equivalents.
  • The direct beneficial ownership of phantom share equivalents includes 133 additional equivalents accrued to the account by the plan administrator on the ex-dividend date.
  • Phantom share equivalents are held in a multi-fund, non-qualified deferred compensation plan and will be settled for cash on a 1-for-1 basis upon termination of service to the board of directors.

Sentiment

Score: 6

Explanation: The sentiment is largely neutral to slightly positive. While there is a disposal of common stock, the acquisitions of deferred stock units and phantom shares are part of a compensation plan, aligning the director's interests with the company. The pre-planned nature of the transactions under Rule 10b5-1 also reduces any immediate speculative impact.

Positives

  • Acquisition of 950 common stock-deferred stock units at $43.43 per unit, aligning the director's long-term interests with shareholders.
  • Acquisition of 1,805 deferred phantom share equivalents at $45.01 per equivalent, further aligning the director's compensation with company performance.
  • The transactions are part of a pre-arranged Rule 10b5-1 plan, indicating structured and transparent insider trading practices.

Negatives

  • Disposal of 4,500 shares of common stock by a director, which, while part of a pre-planned transaction, represents a reduction in direct equity holdings.

Future Outlook

The filing details pre-planned future transactions by a director, indicating a structured approach to equity compensation and personal portfolio management under a Rule 10b5-1 plan. These transactions are scheduled for September 30, 2025.

Industry Context

Insider transactions, particularly those executed under Rule 10b5-1 plans, are common in the utilities sector, including companies like Exelon. These plans allow insiders to buy or sell company stock at a predetermined time or price, providing an affirmative defense against insider trading allegations and facilitating long-term compensation strategies.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Compensation Plan DisclosureThe filing references the 'Exelon Corp. Directors Deferred Stock Unit Plan' and a 'multi-fund, non-qualified deferred compensation plan' where phantom share equivalents are held. These plans are part of the company's executive and director compensation structure.09/30/2025Highlights the mechanisms for director compensation and equity alignment, which are standard corporate governance practices.

Related Party Transactions

  • The acquisition of deferred stock units and phantom share equivalents are part of compensation plans provided by Exelon Corp. to its director, William P Bowers, which are considered related party transactions in the context of executive compensation.

Stakeholder Impact

  • Shareholders: The transactions are routine insider activities, likely under a 10b5-1 plan, and are unlikely to have a significant immediate impact on shareholder value. They reflect ongoing director compensation and personal financial planning.
  • Employees: No direct impact on employees is indicated by this filing.

Key Dates

DateDescription
09/30/2025Date of earliest transaction reported, including acquisition of deferred stock units and phantom shares, and disposal of common stock.
10/01/2025Signature date of the reporting person's attorney-in-fact.

Recommendation

hold

This Form 4 details a director's planned future equity transactions, including both acquisitions of deferred compensation units and a disposal of common stock. These appear to be routine compensation and portfolio management activities, likely under a Rule 10b5-1 plan, and do not provide sufficient new information to alter an existing investment thesis for Exelon. Therefore, a 'hold' recommendation is appropriate.

Keywords

Exelon, EXC, Form 4, Insider Transaction, Director, Stock Units, Phantom Shares, Deferred Compensation, Rule 10b5-1

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.